Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours (REVASCAT)

This study has been terminated.
(Following DSMB advice after first interim analysis (n=174))
Sponsor:
Collaborator:
Covidien
Information provided by (Responsible Party):
Fundacio Ictus Malaltia Vascular
ClinicalTrials.gov Identifier:
NCT01692379
First received: September 20, 2012
Last updated: December 15, 2014
Last verified: December 2014